What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?
Author:
Affiliation:
1. Section of Infectious Diseases, Department of Clinical Medicine and Surgery, University of Naples ‘Federico II’, Naples, Italy
Funder
not funded
Publisher
Informa UK Limited
Subject
Virology,Infectious Diseases,Microbiology (medical),Microbiology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14787210.2016.1233060
Reference44 articles.
1. Access to effective antimicrobials: a worldwide challenge
2. Centers for Diseases Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. [cited 2016 July 15] Available from: http://www.cdc.gov/drugresistance/threat-report-2013/.
3. Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications
4. Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options
5. Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa collected in the Study for Monitoring Antimicrobial Resistance Trends (SMART) between 2016 and 2019 in China;International Journal of Antimicrobial Agents;2023-04
2. Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion;Antibiotics;2022-09-17
3. New β-Lactam Antibiotics and Ceragenins – A Study to Assess Their Potential in Treatment of Infections Caused by Multidrug-Resistant Strains of Pseudomonas aeruginosa;Infection and Drug Resistance;2021-12
4. Ceftolozane/Tazobactam for Resistant Drugs Pseudomonas aeruginosa Respiratory Infections: A Systematic Literature Review of the Real-World Evidence;Life;2021-05-24
5. Ceftazidime–avibactam and ceftolozane–tazobactam susceptibility of multidrug resistant Pseudomonas aeruginosa strains in Hungary;Acta Microbiologica et Immunologica Hungarica;2020-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3